Lista de obras -

A cellular antidote to specifically deplete anti-CD19 chimeric antigen receptor-positive cells

artículo científico publicado en 2020

Abstracts of the 29th Annual Scientific Meeting of the Society for Immunotherapy of Cancer (SITC)

Approaches of T Cell Activation and Differentiation for CAR-T Cell Therapies

artículo científico publicado en 2020

CAR T-Cell Therapies in Glioblastoma: A First Look

artículo científico publicado en 2017

Cancer Killers.

artículo científico publicado en 2017

Checkpoint Blockade Reverses Anergy in IL-13Rα2 Humanized scFv-Based CAR T Cells to Treat Murine and Canine Gliomas

artículo científico publicado en 2018

Combination Therapy for Solid Tumors: Taking a Classic CAR on New Adventures

artículo científico publicado en 2020

Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells

artículo científico publicado en 2016

Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells

artículo científico publicado en 2016

Distinguishing Truncated and Normal MUC1 Glycoform Targeting from Tn-MUC1-Specific CAR T Cells: Specificity Is the Key to Safety

artículo científico publicado en 2016

Diversity Is a Strength of Cancer Research in the U.S.

scientific article published on 01 September 2020

Driving cars to the clinic for solid tumors

artículo científico publicado en 2018

EHD1 mediates vesicle trafficking required for normal muscle growth and transverse tubule development

artículo científico publicado en 2014

Endocytic recycling proteins EHD1 and EHD2 interact with fer-1-like-5 (Fer1L5) and mediate myoblast fusion

scientific journal article

Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma

scientific article published on June 2016

Engineering and Design of Chimeric Antigen Receptors

article by Sonia Guedan et al published 15 March 2019 in Molecular Therapy. Methods & Clinical Development

Enhancing CAR T cell persistence through ICOS and 4-1BB costimulation.

artículo científico publicado en 2018

Enhancing T cell persistence of CAR-redirected T cells in solid tumors

artículo científico publicado en 2014

Expanding the Therapeutic Window for CAR T Cell Therapy in Solid Tumors: The Knowns and Unknowns of CAR T Cell Biology

article by Keisuke Watanabe et al published 26 October 2018 in Frontiers in Immunology

Ferlin proteins in myoblast fusion and muscle growth.

artículo científico publicado en 2011

GLYCAN-DIRECTED CAR-T CELLS.

artículo científico publicado en 2018

Generation and Validation of an Antibody to Canine CD19 for Diagnostic and Future Therapeutic Purposes

scientific article published on 21 February 2020

ICOS-based chimeric antigen receptors program bipolar TH17/TH1 cells

artículo científico publicado en 2014

Identification of chimeric antigen receptors that mediate constitutive or inducible proliferation of T cells

artículo científico publicado en 2015

Immunotherapy for Breast Cancer: Current and Future Strategies.

artículo científico publicado en 2017

Improving CART-Cell Therapy of Solid Tumors with Oncolytic Virus-Driven Production of a Bispecific T-cell Engager

artículo científico publicado en 2018

Keeping the Engine Running: The Relevance and Predictive Value of Preclinical Models for CAR-T Cell Development

scientific article published on 01 December 2018

Measurement of intracellular ions by flow cytometry

artículo científico publicado en 2015

Multiple cancer-specific antigens are targeted by a chimeric antigen receptor on a single cancer cell

scientific article published on 01 November 2019

Multiple cancer-specific antigens are targeted by a chimeric antigen receptor on a single cancer cell

artículo científico publicado en 2019

Myoferlin is required for insulin-like growth factor response and muscle growth

artículo científico publicado en 2009

Normal myoblast fusion requires myoferlin

artículo científico publicado en 2005

Rational development and characterization of humanized anti-EGFR variant III chimeric antigen receptor T cells for glioblastoma

artículo científico publicado en 2015

Safety and Efficacy of Intratumoral Injections of Chimeric Antigen Receptor (CAR) T Cells in Metastatic Breast Cancer

artículo científico publicado en 2017

Single residue in CD28-costimulated CAR T cells limits long-term persistence and antitumor durability

scientific article published on 18 February 2020

Single-Cell Analyses Identify Brain Mural Cells Expressing CD19 as Potential Off-Tumor Targets for CAR-T Immunotherapies

scientific article published on 11 September 2020

The endocytic recycling protein EHD2 interacts with myoferlin to regulate myoblast fusion.

artículo científico publicado en 2008

Lista de obras de

A cellular antidote to specifically deplete anti-CD19 chimeric antigen receptor-positive cells

Abstracts of the 29th Annual Scientific Meeting of the Society for Immunotherapy of Cancer (SITC)

Approaches of T Cell Activation and Differentiation for CAR-T Cell Therapies

CAR T-Cell Therapies in Glioblastoma: A First Look

Cancer Killers.

Checkpoint Blockade Reverses Anergy in IL-13Rα2 Humanized scFv-Based CAR T Cells to Treat Murine and Canine Gliomas

Combination Therapy for Solid Tumors: Taking a Classic CAR on New Adventures

Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells

Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells

Distinguishing Truncated and Normal MUC1 Glycoform Targeting from Tn-MUC1-Specific CAR T Cells: Specificity Is the Key to Safety

Diversity Is a Strength of Cancer Research in the U.S.

Driving cars to the clinic for solid tumors

EHD1 mediates vesicle trafficking required for normal muscle growth and transverse tubule development

Endocytic recycling proteins EHD1 and EHD2 interact with fer-1-like-5 (Fer1L5) and mediate myoblast fusion

Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma

Engineering and Design of Chimeric Antigen Receptors

Enhancing CAR T cell persistence through ICOS and 4-1BB costimulation.

Enhancing T cell persistence of CAR-redirected T cells in solid tumors

Expanding the Therapeutic Window for CAR T Cell Therapy in Solid Tumors: The Knowns and Unknowns of CAR T Cell Biology

Ferlin proteins in myoblast fusion and muscle growth.

GLYCAN-DIRECTED CAR-T CELLS.

Generation and Validation of an Antibody to Canine CD19 for Diagnostic and Future Therapeutic Purposes

ICOS-based chimeric antigen receptors program bipolar TH17/TH1 cells

Identification of chimeric antigen receptors that mediate constitutive or inducible proliferation of T cells

Immunotherapy for Breast Cancer: Current and Future Strategies.

Improving CART-Cell Therapy of Solid Tumors with Oncolytic Virus-Driven Production of a Bispecific T-cell Engager

Keeping the Engine Running: The Relevance and Predictive Value of Preclinical Models for CAR-T Cell Development

Measurement of intracellular ions by flow cytometry

Multiple cancer-specific antigens are targeted by a chimeric antigen receptor on a single cancer cell

Multiple cancer-specific antigens are targeted by a chimeric antigen receptor on a single cancer cell

Myoferlin is required for insulin-like growth factor response and muscle growth

Normal myoblast fusion requires myoferlin

Rational development and characterization of humanized anti-EGFR variant III chimeric antigen receptor T cells for glioblastoma

Safety and Efficacy of Intratumoral Injections of Chimeric Antigen Receptor (CAR) T Cells in Metastatic Breast Cancer

Single residue in CD28-costimulated CAR T cells limits long-term persistence and antitumor durability

Single-Cell Analyses Identify Brain Mural Cells Expressing CD19 as Potential Off-Tumor Targets for CAR-T Immunotherapies

The endocytic recycling protein EHD2 interacts with myoferlin to regulate myoblast fusion.